Substantial studies have demonstrated that IL-6 is involved in a variety of autoimmune and chronic inflammatory diseases, such as inflammatory bowel disease (IBD), diabetes, rheumatoid arthritis (RA), multiple sclerosis, asthma and most recently, COVID-19 pneumonia (7, 10–13). Here, IL6 is linked to inflammatory bowel disease.